An Open-Label Phase 4 Single-Arm Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy with Tofacitinib in Adult Patients with Moderately to Severely Active Ulcerative Colitis

Brief description of study

This is a phase 4, interventional, open-label, single-arm, multicenter study in adult participants with moderately to severely active ulcerative colitis (UC) who have experienced inadequate response, loss of response, or intolerance to no more than 2 prior TNF-a (tumor necrosis factor alpha) antagonists.

Clinical Study Identifier: s24-00874

ClinicalTrials.gov Identifier: NCT06095128

Principal Investigator: David P Hudesman.

Other Investigators: Elie S Al Kazzi, Shannon Chang, Adam Faye, Simon J Hong, Ariela Holmer, Jordan E Axelrad, Lindsay Clarke.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies